文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停后血清中性粒细胞明胶酶相关脂质运载蛋白预测长期结局

Predicting long-term outcomes after cardiac arrest by using serum neutrophil gelatinase-associated lipocalin.
PubMed 文献 · Am J Emerg Med · 2017-12-07
一句话结论心脏骤停后72小时血清NGAL与6个月不良结局相关,但预测效能有限(AUC=0.72),作者认为应作为附加预后手段。

这项前瞻性观察研究加回顾性分析纳入76例接受目标温度管理的成人院外心脏骤停幸存者,在自主循环恢复后0、24、48、72小时检测血清NGAL。主要终点为心脏骤停后6个月不良结局(脑功能分级3-5分),次要终点为6个月死亡率。不良结局组24、48、72小时NGAL水平显著高于良好结局组;高NGAL组各时间点长期生存率显著低于低NGAL组;存活72小时亚组中仅72小时NGAL有预后价值(AUC=0.72,p=0.02)。作者结论认为NGAL预测效能不令人满意,应作为附加预后手段。

要点

  • 76例目标温度管理的成人院外心脏骤停幸存者中,不良结局组24、48、72小时血清NGAL显著高于良好结局组。
  • 高NGAL组各时间点长期生存率显著低于低NGAL组。
  • 存活72小时亚组中,仅72小时NGAL对长期结局有预后价值(AUC=0.72,p=0.02)。
  • 作者认为心脏骤停后3天是预测长期结局的最佳时间点。
  • 作者认为NGAL预测效能不令人满意,应作为附加预后手段。

适用人群与场景

  • 成人院外心脏骤停幸存者,接受目标温度管理。

诊断标准与关键阈值

  • 主要结局:心脏骤停后6个月不良结局,定义为脑功能分级(cerebral performance category)评分3-5分。
  • 次要结局:6个月死亡率。

研究设计与关键结果

  • 研究类型:前瞻性观察研究加回顾性分析;样本量76例;人群为接受目标温度管理的成人院外心脏骤停幸存者。
  • 血清NGAL检测时间点:自主循环恢复后0、24、48、72小时。
  • 不良结局组24、48、72小时NGAL水平显著高于良好结局组。
  • 高NGAL组各时间点长期生存率显著低于低NGAL组。
  • 存活72小时亚组中,仅72小时血清NGAL对长期结局有预后价值(AUC=0.72;p=0.02)。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究加回顾性分析。
  • 作者结论:NGAL预测效能不令人满意,应作为附加预后手段。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为心脏骤停后3天(72小时)是预测长期结局的最佳时间点。
  • 作者认为NGAL预测效能不令人满意,应作为附加预后手段。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Neutrophil gelatinase-associated lipocalin (NGAL) is secreted by various tissues in pathologic states. Previous studies reported that post-cardiac arrest serum NGAL levels correlate with short-term neurologic outcomes and survival. The aim of this study was to examine the associations between NGAL levels post-cardiac arrest and long-term outcomes and survival.

METHODS: This prospective observational study and retrospective review included adult out-of-hospital cardiac arrest survivors who were treated by hypothermia-targeted temperature management. Serum NGAL was assessed at 0, 24, 48, and 72h after return of spontaneous circulation. The primary outcome was poor outcome at six months after cardiac arrest, defined as cerebral performance category score of 3-5. The secondary outcome was six-month mortality.

RESULTS: In total, 76 patients were analyzed. The patients with poor outcomes showed significantly higher NGAL levels at 24, 48 and 72h after cardiac arrest than the patients with good outcomes. Long-term survival rates were significantly lower in the high-NGAL group than in the low-NGAL group at each time point. Subgroup analysis of patients who survived 72h showed that only serum NGAL 72h after cardiac arrest had prognostic value for long-term outcomes (area under the receiver operating characteristic curve=0.72; p=0.02).

CONCLUSIONS: Post-cardiac arrest serum NGAL is associated with long-term outcomes and survival; particularly, three days post-cardiac arrest is the optimal time point for predicting long-term outcomes. However, the predictive power of NGAL is unsatisfactory, and it should be regarded as an additional prognostic modality.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Park YR, Oh JS, Jeong H, et al. Predicting long-term outcomes after cardiac arrest by using serum neutrophil gelatinase-associated lipocalin. Am J Emerg Med. 2017. PMID: 29317152. doi:10.1016/j.ajem.2017.12.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。